Biomerica (BMRA) Stock Chart & Stock Price History → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free BMRA Stock Alerts $0.67 -0.01 (-1.51%) (As of 05:27 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Biomerica Stock Price Performance5 Day Performance-8.91%1 Month Performance-25.26%3 Month Performance-26.45%6 Month Performance-29.23%Year-To-Date Performance-46.78%1 Year Performance-46.35% Receive BMRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biomerica and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. BMRA Stock Chart for Friday, April, 26, 2024 BMRA Chart by TradingView Biomerica Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024$0.71$0.68-4.63%$0.73$0.67121,965 shs$11.44 million04/24/2024$0.72$0.71-1.25%$0.80$0.67660,147 shs$11.99 million04/23/2024$0.72$0.72-0.37%$0.78$0.7248,549 shs$12.14 million04/22/2024$0.73$0.72-0.77%$0.76$0.7059,331 shs$12.19 million04/19/2024$0.76$0.73-3.91%$0.77$0.7335,160 shs$12.28 million04/18/2024$0.75$0.76+1.20%$0.81$0.7454,965 shs$12.78 million Get the Latest News and Ratings for BMRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biomerica and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024$0.74$0.75+1.71%$0.79$0.7535,885 shs$12.63 million04/16/2024$0.77$0.74-4.11%$0.81$0.7363,942 shs$12.42 million04/15/2024$0.83$0.77-7.00%$0.83$0.77132,974 shs$12.95 million04/12/2024$0.81$0.83+1.97%$0.85$0.8161,031 shs$13.93 million04/11/2024$0.81$0.81+0.25%$0.89$0.81280,155 shs$13.66 million04/10/2024$0.83$0.81-1.87%$0.88$0.8125,811 shs$13.62 million04/09/2024$0.81$0.83+1.79%$0.85$0.8126,498 shs$13.88 million04/08/2024$0.84$0.81-3.48%$0.89$0.8152,492 shs$13.64 million04/05/2024$0.84$0.83-0.32%$0.88$0.8280,406 shs$14.04 million04/04/2024$0.83$0.84+0.31%$0.85$0.8220,396 shs$14.08 million04/03/2024$0.86$0.83-2.50%$0.88$0.8238,274 shs$14.04 million04/02/2024$0.85$0.86+0.39%$0.91$0.8378,192 shs$14.40 million04/01/2024$0.83$0.85+2.46%$0.91$0.8460,857 shs$14.34 million03/29/2024$0.83$0.83$0.95$0.8283,983 shs$13.99 million03/28/2024$0.89$0.83-6.52%$0.95$0.8283,946 shs$13.99 million03/27/2024$0.89$0.89$0.90$0.8562,636 shs$14.97 million03/26/2024$0.87$0.89+2.26%$0.91$0.8450,554 shs$14.97 million03/25/2024$0.89$0.87-1.95%$0.95$0.84134,011 shs$14.64 million03/22/2024$1.00$0.89-11.24%$1.03$0.85141,796 shs$14.93 million03/21/2024$1.08$1.00-7.41%$1.08$0.9920,889 shs$16.82 million03/20/2024$1.11$1.08-2.70%$1.19$1.0340,463 shs$18.17 million03/19/2024$1.08$1.11+3.26%$1.14$1.0624,229 shs$18.67 million03/18/2024$1.06$1.08+1.42%$1.13$1.0517,465 shs$18.08 million03/15/2024$1.03$1.06+2.91%$1.08$1.0321,072 shs$17.83 million03/14/2024$1.02$1.03+0.98%$1.08$1.0037,556 shs$17.33 million03/13/2024$1.02$1.02$1.06$1.0129,945 shs$17.16 million03/12/2024$1.05$1.02-2.86%$1.09$1.0126,441 shs$17.16 million03/11/2024$1.09$1.05-3.67%$1.10$1.0329,283 shs$17.66 million03/08/2024$1.14$1.09-4.39%$1.16$1.0839,633 shs$18.33 million03/07/2024$1.17$1.14-2.56%$1.19$1.1215,503 shs$19.18 million03/06/2024$1.21$1.17-3.31%$1.24$1.1747,637 shs$19.68 million03/05/2024$1.22$1.21-0.82%$1.25$1.2017,692 shs$20.35 million03/04/2024$1.20$1.22+1.67%$1.25$1.1920,759 shs$20.52 million03/01/2024$1.22$1.20-1.64%$1.24$1.1830,070 shs$20.18 millionThe Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late.02/29/2024$1.23$1.22-0.81%$1.24$1.2115,931 shs$20.52 million02/28/2024$1.25$1.23-1.60%$1.27$1.2129,254 shs$20.69 million02/27/2024$1.21$1.25+3.31%$1.34$1.2060,888 shs$21.03 million02/26/2024$1.29$1.21-6.20%$1.33$1.1396,551 shs$20.35 million02/23/2024$1.15$1.29+12.50%$1.35$1.15200,807 shs$21.70 million02/22/2024$1.08$1.15+6.18%$1.16$1.04113,620 shs$19.29 million02/21/2024$1.03$1.08+5.37%$1.09$1.0353,397 shs$18.17 million02/20/2024$1.06$1.03-3.30%$1.06$1.0150,023 shs$17.24 million02/19/2024$1.06$1.06$1.08$0.97110,000 shs$17.83 million02/16/2024$0.97$1.06+9.59%$1.08$0.97109,666 shs$17.83 million02/15/2024$0.99$0.97-2.31%$0.98$0.9437,137 shs$16.27 million02/14/2024$0.99$0.99+0.01%$1.02$0.9557,920 shs$16.65 million02/13/2024$0.95$0.99+4.16%$1.00$0.9579,549 shs$16.65 million02/12/2024$0.93$0.95+2.38%$0.99$0.9030,282 shs$15.99 million02/09/2024$0.85$0.93+9.13%$0.94$0.8334,494 shs$15.62 million02/08/2024$0.86$0.85-1.40%$0.89$0.8163,438 shs$14.31 million02/07/2024$0.86$0.86+0.91%$0.93$0.84129,194 shs$14.51 million02/06/2024$0.85$0.86+0.76%$0.88$0.8432,321 shs$14.38 million02/05/2024$0.91$0.85-6.67%$0.90$0.8393,556 shs$14.27 million02/02/2024$0.91$0.91+0.09%$0.93$0.9036,019 shs$15.29 million02/01/2024$0.93$0.91-2.32%$0.96$0.9050,448 shs$15.28 million01/31/2024$0.93$0.93+0.05%$0.94$0.9117,527 shs$15.64 million01/30/2024$0.96$0.93-3.18%$0.96$0.8944,827 shs$15.63 million01/29/2024$0.90$0.96+6.15%$0.96$0.8938,610 shs$16.15 million01/26/2024$0.92$0.90-1.70%$0.92$0.8836,538 shs$15.21 million01/25/2024$0.95$0.92-3.14%$0.99$0.9124,182 shs$15.47 million Related Companies: Trinity Biotech Stock Price Chart MyMD Pharmaceuticals Stock Price Chart Navidea Biopharmaceuticals Stock Price Chart Cardio Diagnostics Stock Price Chart OncoCyte Stock Price Chart ImmuCell Stock Price Chart Aspira Women's Health Stock Price Chart ARCA biopharma Stock Price Chart Benitec Biopharma Stock Price Chart Genetic Technologies Stock Price Chart Receive BMRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biomerica and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BMRA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomerica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.